vs
Side-by-side financial comparison of Ceribell, Inc. (CBLL) and CHEMUNG FINANCIAL CORP (CHMG). Click either name above to swap in a different company.
Ceribell, Inc. is the larger business by last-quarter revenue ($24.8M vs $23.8M, roughly 1.0× CHEMUNG FINANCIAL CORP). CHEMUNG FINANCIAL CORP runs the higher net margin — 32.5% vs -54.6%, a 87.0% gap on every dollar of revenue. CHEMUNG FINANCIAL CORP produced more free cash flow last quarter ($43.8M vs $-11.0M).
Ceribell, Inc. develops and commercializes innovative portable neurodiagnostic medical devices, focused on rapid non-invasive electroencephalogram (EEG) solutions for seizure detection. Its core products serve hospital emergency departments, intensive care units, and long-term care facilities, with primary markets across North America and ongoing global expansion efforts.
Chemung Canal Trust Company is a New York State chartered trust company based in Elmira, New York. It was founded as a publicly traded bank in 1833.
CBLL vs CHMG — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $24.8M | $23.8M |
| Net Profit | $-13.5M | $7.7M |
| Gross Margin | 87.3% | — |
| Operating Margin | -58.9% | 46.1% |
| Net Margin | -54.6% | 32.5% |
| Revenue YoY | — | 20.3% |
| Net Profit YoY | — | 30.9% |
| EPS (diluted) | $-0.35 | $1.61 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $24.8M | $23.8M | ||
| Q3 25 | $22.6M | $28.8M | ||
| Q2 25 | $21.2M | $10.1M | ||
| Q1 25 | $20.5M | $25.7M | ||
| Q4 24 | — | $25.9M | ||
| Q3 24 | $17.2M | $24.3M | ||
| Q2 24 | — | $23.4M | ||
| Q1 24 | — | $23.7M |
| Q4 25 | $-13.5M | $7.7M | ||
| Q3 25 | $-13.5M | $7.8M | ||
| Q2 25 | $-13.6M | $-6.5M | ||
| Q1 25 | $-12.8M | $6.0M | ||
| Q4 24 | — | $5.9M | ||
| Q3 24 | $-10.4M | $5.7M | ||
| Q2 24 | — | $5.0M | ||
| Q1 24 | — | $7.0M |
| Q4 25 | 87.3% | — | ||
| Q3 25 | 88.3% | — | ||
| Q2 25 | 88.1% | — | ||
| Q1 25 | 87.9% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 87.3% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -58.9% | 46.1% | ||
| Q3 25 | -64.8% | 35.0% | ||
| Q2 25 | -70.5% | -87.2% | ||
| Q1 25 | -69.3% | 29.9% | ||
| Q4 24 | — | 29.0% | ||
| Q3 24 | -57.8% | 29.8% | ||
| Q2 24 | — | 26.8% | ||
| Q1 24 | — | 38.3% |
| Q4 25 | -54.6% | 32.5% | ||
| Q3 25 | -59.6% | 27.1% | ||
| Q2 25 | -64.4% | -63.9% | ||
| Q1 25 | -62.4% | 23.4% | ||
| Q4 24 | — | 29.8% | ||
| Q3 24 | -60.6% | 23.5% | ||
| Q2 24 | — | 21.3% | ||
| Q1 24 | — | 29.7% |
| Q4 25 | $-0.35 | $1.61 | ||
| Q3 25 | $-0.37 | $1.62 | ||
| Q2 25 | $-0.38 | $-1.35 | ||
| Q1 25 | $-0.36 | $1.26 | ||
| Q4 24 | — | $1.24 | ||
| Q3 24 | $-1.85 | $1.19 | ||
| Q2 24 | — | $1.05 | ||
| Q1 24 | — | $1.48 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $159.3M | $50.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $155.3M | $254.7M |
| Total Assets | $195.8M | $2.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $159.3M | $50.1M | ||
| Q3 25 | $168.5M | $107.6M | ||
| Q2 25 | $177.4M | $320.1M | ||
| Q1 25 | $182.7M | $53.4M | ||
| Q4 24 | — | $47.0M | ||
| Q3 24 | $14.1M | $80.4M | ||
| Q2 24 | — | $70.2M | ||
| Q1 24 | — | $94.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $99.1M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $155.3M | $254.7M | ||
| Q3 25 | $164.1M | $245.3M | ||
| Q2 25 | $172.2M | $235.0M | ||
| Q1 25 | $180.9M | $228.3M | ||
| Q4 24 | — | $215.3M | ||
| Q3 24 | $-136.0M | $220.7M | ||
| Q2 24 | — | $201.2M | ||
| Q1 24 | — | $197.1M |
| Q4 25 | $195.8M | $2.7B | ||
| Q3 25 | $199.5M | $2.7B | ||
| Q2 25 | $207.7M | $2.9B | ||
| Q1 25 | $213.5M | $2.8B | ||
| Q4 24 | — | $2.8B | ||
| Q3 24 | $47.1M | $2.8B | ||
| Q2 24 | — | $2.8B | ||
| Q1 24 | — | $2.8B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.42× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-10.8M | $45.5M |
| Free Cash FlowOCF − Capex | $-11.0M | $43.8M |
| FCF MarginFCF / Revenue | -44.2% | 183.7% |
| Capex IntensityCapex / Revenue | 0.7% | 7.1% |
| Cash ConversionOCF / Net Profit | — | 5.88× |
| TTM Free Cash FlowTrailing 4 quarters | $-41.6M | $71.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-10.8M | $45.5M | ||
| Q3 25 | $-11.1M | $12.2M | ||
| Q2 25 | $-7.5M | $9.7M | ||
| Q1 25 | $-11.4M | $7.2M | ||
| Q4 24 | — | $29.8M | ||
| Q3 24 | — | $9.2M | ||
| Q2 24 | — | $6.5M | ||
| Q1 24 | — | $7.9M |
| Q4 25 | $-11.0M | $43.8M | ||
| Q3 25 | $-11.5M | $11.8M | ||
| Q2 25 | $-7.6M | $9.4M | ||
| Q1 25 | $-11.6M | $6.9M | ||
| Q4 24 | — | $26.2M | ||
| Q3 24 | — | $8.6M | ||
| Q2 24 | — | $5.5M | ||
| Q1 24 | — | $7.9M |
| Q4 25 | -44.2% | 183.7% | ||
| Q3 25 | -50.8% | 41.1% | ||
| Q2 25 | -35.9% | 92.9% | ||
| Q1 25 | -56.4% | 26.7% | ||
| Q4 24 | — | 101.2% | ||
| Q3 24 | — | 35.2% | ||
| Q2 24 | — | 23.4% | ||
| Q1 24 | — | 33.1% |
| Q4 25 | 0.7% | 7.1% | ||
| Q3 25 | 1.6% | 1.4% | ||
| Q2 25 | 0.3% | 3.6% | ||
| Q1 25 | 0.7% | 1.3% | ||
| Q4 24 | — | 14.0% | ||
| Q3 24 | — | 2.5% | ||
| Q2 24 | — | 4.4% | ||
| Q1 24 | — | 0.3% |
| Q4 25 | — | 5.88× | ||
| Q3 25 | — | 1.57× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.19× | ||
| Q4 24 | — | 5.04× | ||
| Q3 24 | — | 1.60× | ||
| Q2 24 | — | 1.30× | ||
| Q1 24 | — | 1.13× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CBLL
| Products | $18.8M | 76% |
| Subscription | $6.0M | 24% |
CHMG
Segment breakdown not available.
